Jon Fox's most recent trade in Edgewise Therapeutics Inc was a trade of 339 Common Stock done . Disclosure was reported to the exchange on April 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Edgewise Therapeutics Inc | Jonathan C. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2026 | 339 | 24,514 | - | 0 | Common Stock | |
| Edgewise Therapeutics Inc | Jonathan C. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 473 | 24,175 | - | 0 | Common Stock | |
| Edgewise Therapeutics Inc | Jonathan C. Fox | Director | Purchase of securities on an exchange or from another person at price $ 18.64 per share. | 11 Nov 2025 | 10,700 | 23,702 | - | 18.6 | 199,403 | Common Stock |
| Edgewise Therapeutics Inc | Fox C. Jonathan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 728 | 13,002 | - | 0 | Common Stock | |
| Edgewise Therapeutics Inc | Jonathan C. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 858 | 12,274 | - | 0 | Common Stock | |
| Edgewise Therapeutics Inc | Jonathan C. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2025 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | Jonathan C. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 559 | 11,416 | - | 0 | Common Stock | |
| Edgewise Therapeutics Inc | Jonathan C. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 20,594 | 20,594 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | C. Jonathan Fox | Director | Purchase of securities on an exchange or from another person at price $ 9.30 per share. | 26 Dec 2023 | 10,857 | 10,857 | - | 9.3 | 100,958 | Common Stock |
| Edgewise Therapeutics Inc | Jonathan C. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 43,731 | 43,731 | - | - | Stock Option (Right to Buy) |